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recently reviewed the literature concerning seizures associated with propofol anaesthesia. However, to our knowledge this is the first case of seizure activity on a second, but not the first exposure to propofol.
CASE REPORT First Admission
A 23-year-old, 60 kg female (ASA 1) presented in December 1993 for suction curettage of the uterus to terminate pregnancy. There was no family or past history of epilepsy and she took no regular medication or illicit drugs. She smoked 10 cigarettes per day, had no allergies, and drank 20g of ethanol per week. She was otherwise well, having been in hospital only for the birth of her two children three years and 18 months prior to this admission. General anaesthesia was induced with propofol 120 mg and lignocaine 12 mg, fentanyl 50 µg and droperidol 1 mg intravenously (IV) and maintained with isoflurane 1.2%, nitrous oxide 70% and oxygen. Her intraoperative course, recovery and postoperative period were unremarkable and she was discharged home later the same day.
Second Admission
She represented for dilatation, curettage and laparoscopy for inevitable miscarriage in December 1994. At this time she weighed 64kg. Preoperative assessment was unremarkable. Anaesthesia was induced at 6.15 pm with 150 mg of propofol with lignocaine 15mg, fentanyl 100 µg and atracurium 25 mg IV. A further bolus of propofol 50 mg with lignocaine 5 mg IV was administered immediately prior to intubation three minutes after induction. Following intubation with a 7.5mm oral endotracheal tube anaesthesia was maintained with isoflurane 1.5%, 70% nitrous oxide and oxygen. The patient was ventilated to an end-tidal carbon dioxide tension of 31-32 mmHg. All surgical wound sites were infiltrated with 0.25% bupivacaine with adrenaline 1:200,000 to a total dose of 10 ml. Her intraoperative course was unremarkable and at the conclusion of the 30 minute procedure a 100 mg indomethacin suppository was given per rectum and the neuromuscular blockade was antagonized with neostigmine 2.5mg and atropine 1.2mg IV. She was responding to verbal command prior to transfer from the operating theatre.
On arrival in the recovery room she had three violent tonic-clonic seizures of 60-90 seconds duration, the first of which occurred at 7.05 pm. These did not respond to treatment with midazolam 3mg IV but were controlled with thiopentone 75 mg on each occasion. Between seizures she was localizing pain, would not open her eyes and was making no sound. Neurological examination showed generally brisk reflexes. Plantar responses were initially equivocal but shortly afterward normal. Her fundi were normal and there were no focal neurological signs. She was not incontinent at any stage. At no time did the oxygen saturation fall from 100%. The blood sugar level was 6.2 mmol/l. Arterial blood pressure (114/61 mmHg), pulse (85 min -1 ) and temperature (36.7°C) were normal. The patient was intubated following thiopentone 300 mg and succinylcholine 100 mg IV, maintained on 100% oxygen with intermittent positive pressure ventilation (IPPV), and transferred to the intensive care unit (ICU) at 9.20 pm for management of her ongoing seizures. Morphine and midazolam sedation at 3 mg per hour by IV infusion, and neuromuscular blockade with vecuronium 8 mg as a bolus IV was used during transport.
Following arrival in ICU she was sedated overnight with continuing IPPV. A specialist neurologist was consulted and a loading dose of phenytoin 1 gm IV was administered. Arterial blood gases (pH 7.38, P a CO 2 37.5 mmHg, P a O 2 166.7 mmHg, BE-1.5 mmol/l), electrolytes and liver function tests were all normal. Apart from a mildly elevated leukocyte count (13.9) with predominant neutrophilia, which normalized the next day, her full blood count was normal. She was mildly febrile throughout her admission with axillary temperatures ranging from 36.8 on admission to 37.9°C. Her Computerised Tomography (CT) scan of the head was normal with no focal abnormality or intracranial haemorrhage detected. Lumbar puncture was not performed.
At 5.45 am and 5.55 am the following day, she had a further two seizures despite her midazolam and phenytoin. Again they were generalized tonic-clonic seizures of 45-90 seconds duration, ceased spontaneously, and no treatment was given. The morphine and midazolam infusion was abandoned two hours later aiming to allow further assessment of her neurological status and possible extubation. Clonazepam 1 mg IV was used as required to control further seizures. An electroencephalogram (EEG) was performed three hours after the cessation of her sedative infusion. During this examination the patient was asleep and had no periods of clinical seizure activity. Only normal stage 2 sleep was detected on the EEG record. There were a further four seizures beginning at 11.30 am and continuing almost hourly until 2.15 pm with a further isolated seizure at 6.40 pm. Each seizure was tonic-clonic in nature and of 1 to 2 minutes duration. Each was promptly controlled with 1 mg of clonazepam IV. She was extubated uneventfully late that evening, was alert and had developed no focal neurological signs.
There were two further episodes of abnormal movement early the next morning which involved arrhythmic jerking of all limbs of one minute duration. There was no post-ictal period, and she gave appropriate responses to questions and showed purposeful movements within one minute. She was alert and had suffered no incontinence.
She had no further seizures in the subsequent 24 hours and was discharged home, otherwise well, with a provisional diagnosis of propofol induced seizures for follow-up by her general practitioner.
DISCUSSION
To our knowledge this is the first case report of a patient suffering seizures following a propofol anaesthetic despite a previous uneventful exposure to propofol. To elicit a likely cause for her seizures we examined similarities and differences in each anaesthetic technique (Table 1) .
On both occasions that the patient received propofol she was pregnant, although on the second she was suffering a miscarriage. Possible causes for this reaction include miscarriage, although this has not been reported as an association with propofolinduced seizures, or the other agents she received during her second procedure. Other possible causes include hypocarbia, infection and intracranial pathology. Hypocarbia was not noted at any stage on endtidal or arterial blood gas measurement. There was no evidence that her mild fever was associated with intracranial pathology, consistent with her normal CT scan and EEG.
During her second anaesthetic the patient received twice the dose of propofol, a slightly higher dose of lignocaine but no droperidol. Nitrous oxide and isoflurane were used in similar concentrations to her first anaesthetic and she received atracurium, bupivacaine, neostigmine and atropine for the first time.
Atracurium is not epileptogenic, but breaks down into laudanosine, among other compounds which have been reported to produce seizures 2, 3, 4, 5 . The reported plasma concentration of laudanosine required to produce seizures is 17 µg/ml in dogs and 3 µg/ml in rabbits. Levels up to 5.5 µg/ml have been found in patients receiving prolonged infusions of atracurium in ICU. Seizures were not reported in this group, but may have gone undetected because of their neuromuscular blockade. Up to 1 µg/ml has been found in blood of anephric patients undergoing renal transplantation with atracurium infusions of 3 to 5 µg/kg/min. It would seem unlikely that a single dose of 25 mg of atracurium in a patient with normal renal function would produce a sufficient concentration of laudanosine to provoke seizures. Both lignocaine and bupivacaine are capable of producing seizures, however both these drugs were given at doses substantially less than the maximum safe doses of 5 mg/kg and 2 mg/kg (without adrenaline) respectively 6 . Lignocaine when used with propofol may provide some protection against excitatory phenomena produced by propofol 7 . Atropine can produce convulsions, but the dose required is above 10mg which is more than eight times the dose administered to the patient 6 . Anticholinesterase agents in toxic doses can produce convulsions, but this is seen typically with more lipid-soluble compounds. Neostigmine is relatively poorly lipid-soluble because of its quarternary ammonium structure, and has difficulty penetrating the blood-brain barrier. It is therefore unlikely to produce seizures in therapeutic doses 5 . Opioid drugs exhibiting predominant delta receptor agonist activity are capable of producing seizures 6 . Fentanyl is predominantly a mu receptor agonist and seems to have a biphasic effect on seizure threshold. In animal models low doses of fentanyl (100 to 200 µg) reduced seizure threshold while at high doses it was raised 5 . The literature from human case reports is conflicting 8, 9 , but suggests that the seizure-like motor activity with low dose fentanyl is not seen on simultaneous EEG recordings and may be either sub-cortical fitting or simply opioid-induced muscle rigidity 10 . One documented (EEG) series of fentanyl induced seizures, notably occurring at high dose (17.7 to 35.7 µg/kg), has been reported in humans 10 . These seizures following induction with fentanyl were short-lived, in contrast to our patient who had a low dose of fentanyl and recurrent seizures over 36 hours.
Isoflurane per se has not been reported to produce seizures in humans in clinically applied concentrations, and rarely has been seen with seizure-like activity when given with nitrous oxide 5 . Nitrous oxide has been reported to produce withdrawal seizures in animals. However, in humans there have been no documented (EEG) episodes of seizures with nitrous oxide and only one case report of seizures when given in combination with halothane 5 . Seizures have not been reported following exposure to intralipid, the soybean oil emulsion used as a vehicle for propofol. Interaction has not been described between propofol and intralipid.
Propofol has been proposed in the literature as both a proconvulsant and a treatment for status epilepticus 1, 11, 12, 13 . Possible mechanisms for seizure production by propofol include effects on glycine-mediated neurotransmission, unknown proconvulsant metabolites or by interaction with other agents 14, 15 . During the first anaesthetic the patient received 2 mg/kg of propofol as a bolus and on the second occasion she received 3.1 mg/kg of propofol in divided doses. Whether the precipitation of seizures by propofol is dose-dependent is unclear. Recent anecdotal evidence suggests that propofol may not be proconvulsant in its own right, but that it may open the door for seizures elicited by other mechanisms 15 .
There are several worrying features about this case: firstly, it is now clear that a prior history of uneventful exposure to propofol is no guarantee that seizure activity will not occur during a subsequent administration of the drug; secondly, that concomitant use of neuromuscular blockade may conceal the true incidence of proconvulsant activity leading to underreporting of such problems; and thirdly, despite its short half-life, seizure activity following a single bolus injection of propofol can persist for a prolonged period of time which in this case was over 36 hours.
Although the underlying mechanism of these seizures is currently unknown, propofol seems on balance to be the most likely trigger and we support the call by Sutherland and Burt for further research into this area.
